Disorders of male genital organs in diseases classified elsewhere

N14_MALEGENINOTH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N51* Cause of death: ICD-10 — N51* 2 out of 7 registries used, show all original rules.	225
4. Check minimum number of events None	225
5. Include endpoints None	225
6. Filter based on genotype QC (FinnGen only)	225

Control definitions (FinnGen only)

Control exclude: N14_MALEGEN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_MALEGENINOTH
CONTROL_EXCLUDE	N14_MALEGEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N51
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N51
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of male genital organs in diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2125	-	2125
Only index persons	2038	-	2038
Unadjusted period prevalence (%)
Whole population	0.06	-	0.06
Only index persons	0.08	-	0.08
Median age at first event (years)
Whole population	-	-	34.45
Only index persons	-	-	34.35

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	225	-	225
Unadjusted period prevalence (%)	0.10	-	0.10
Median age at first event (years)	46.54	-	46.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
201: Matched controls
2009

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

714.2

90.9

N51.2*B37.4

ICD-10 Finland

Candidal balanitis

+∞

44.4

N51.2

ICD-10 Finland

Balanitis in diseases classified elsewhere

+∞

29.9

N51.8

ICD-10 Finland

Other disorders of male genital organs in diseases classified elsewhere

+∞

24.5

J05AB11

ATC

valaciclovir; oral

8.2

24.1

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

9.3

21.2

J05AB01

ATC

aciclovir; systemic

5.8

20.4

152

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

81.6

20.1

N48.1

ICD-10 Finland

Balanoposthitis

16.6

18.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

4.0

15.1

240

J02AC01

ATC

fluconazole; systemic

3.8

12.3

192

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

23.0

12.2

N40

ICD-10 Finland

Hyperplasia of prostate

4.6

12.2

119

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

5.4

11.3

N51.1

ICD-10 Finland

Disorders of testis and epididymis in diseases classified elsewhere

115.8

10.5

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

34.5

10.5

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

6.6

10.2

N41.1

ICD-10 Finland

Chronic prostatitis

15.7

10.2

KGH10

NOMESCO Finland

Operation for phimosis

42.3

10.1

J01MA02

ATC

ciprofloxacin; systemic

2.7

9.5

437

J01MA01

ATC

ofloxacin; systemic

5.5

8.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.4

8.3

103

606

G04CA01

ATC

alfuzosin; oral

3.4

8.3

139

N02AX02

ATC

tramadol; systemic, rectal

2.3

7.6

539

N48.8

ICD-10 Finland

Other specified disorders of penis

83.0

7.5

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

12.7

7.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.1

7.1

149

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.4

6.9

109

XKD00

NOMESCO Finland

Uroflowmetry

3.4

6.9

109

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

9.2

6.7

J01DA01

ATC

[U] cefalexin; systemic

2.1

6.3

122

843

A18.1

ICD-10 Finland

Tuberculosis of genitourinary system

+∞

6.3

KGB00

NOMESCO Finland

Biopsy of penis

+∞

6.3

KFC00

NOMESCO Finland

Unilateral orchiectomy

27.6

6.3

N03AF01

ATC

carbamazepine; oral, rectal

4.7

6.2

UKC02

NOMESCO Finland

Cystoscopy

3.3

6.1

102

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

173

4.67

21.83

2.2

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

193

4.42

21.03

2.2

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

12.96

18.02

1.2

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

144

847

2.94

13.60

4.2

3.1

—

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

158

1005

2.92

12.39

5.2

3.4

—

(3019225) pH of Specimen

125

3.68

11.18

3.5

4.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

102

3.88

10.80

1.6

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

166

3.23

10.25

4.5

3.8

30.3

28.3

0.49

116

(46235355) HIV 1 and 2 tests - Meaningful Use set

326

2.61

9.31

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

10.42

8.70

1.1

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

172

1262

2.54

8.25

9.2

8.1

u/l

73.9

79.2

0.68

166

1201

(3013707) Erythrocyte sedimentation rate by Westergren method

161

1149

2.41

8.18

5.2

3.7

mm/h

9.7

11.2

0.51

149

1065

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

209

1720

4.03

7.64

17.2

13.1

mg/l

20.8

26.0

1.47

175

1358

(3024561) Albumin [Mass/volume] in Serum or Plasma

108

669

2.18

7.55

7.3

5.2

g/l

37.1

36.3

0.63

102

629

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

126

836

2.15

7.32

6.5

7.1

umol/l

10.8

12.6

2.45

121

810

(3022145) Colonoscopy Study observation

175

2.72

7.13

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

112

728

2.07

6.67

9.9

8.6

mmol/l

1.2

0.41

100

629

(3013115) Eosinophils [#/volume] in Blood

122

835

2.01

6.14

7.0

6.7

e9/l

0.2

0.32

111

739

(42870588) Differential panel, method unspecified - Blood

543

2.02

5.88

7.2

6.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

101

657

1.97

5.78

8.8

7.9

mmol/l

1.2

0.15

609

(3009508) Creatinine [Moles/volume] in Urine

534

1.99

5.59

5.0

3.3

mmol/l

9.0

8.9

0.07

454

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

11.65

5.34

1.2

1.1

mmol/l

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3.54

5.29

1.7

2.8

—

(3001604) Monocytes [#/volume] in Blood

117

818

1.90

5.26

6.9

6.1

e9/l

0.6

0.55

109

707

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3.28

5.21

4.2

3.3

—

(3000494) Fungus identified in Specimen by Culture

196

2.34

5.18

1.4

1.6

—

(3006315) Basophils [#/volume] in Blood

117

821

1.89

5.17

6.9

6.1

e9/l

0.0

0.01

109

716

(40768443) Skin Pathology biopsy report

3.47

5.15

1.4

—

(3032080) INR in Blood by Coagulation assay

660

1.89

5.11

8.4

7.6

inr

1.3

1.2

0.15

183

(3022096) Basophils/100 leukocytes in Blood

108

748

1.85

4.89

7.2

6.3

0.6

0.7

0.37

102

720

(3019198) Lymphocytes [#/volume] in Blood

118

841

1.85

4.87

6.9

6.3

e9/l

1.9

1.8

0.95

108

743

(3028679) Herpes simplex virus Ab [Presence] in Serum

11.79

4.82

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

189

2.29

4.76

1.2

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

110

771

1.83

4.76

7.4

6.6

9.4

9.0

0.89

104

743

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

672

1.85

4.75

4.4

3.9

—

(3018010) Neutrophils/100 leukocytes in Blood

111

784

1.82

4.65

6.9

6.2

54.5

57.5

1.89

104

756

(3037522) Nuclear Ab [Titer] in Serum

191

2.26

4.64

1.5

1.4

titre

340.0

269.4

—

(3006504) Eosinophils/100 leukocytes in Blood

109

768

1.81

4.59

7.3

6.2

3.0

0.10

103

735

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

642

1.83

4.58

4.3

3.3

ng/l

29.2

58.4

1.62

434

(3002030) Lymphocytes/100 leukocytes in Blood

112

796

1.81

4.57

7.3

6.3

29.3

26.7

1.93

104

764

(3013512) EKG study

431

1.91

4.51

4.7

3.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3.37

4.43

1.6

2.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

284

2.03

4.38

2.3

2.2

nmol/l

13.5

14.5

0.38

259

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.01

4.34

2.5

2.2

—

(3009343) pH of Capillary blood

104

2.58

4.23

2.8

3.3

—

7.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

250

2.06

4.21

1.8

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

127

952

1.77

4.21

6.6

6.0

mmol/l

7.0

6.9

0.16

122

911

(3022313) Gas panel - Capillary blood

2.69

3.93

2.6

3.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

509

1.78

3.88

2.4

2.2

nmol/l

70.6

72.8

0.26

464

(3022621) pH of Urine by Test strip

2.79

3.84

2.1

2.7

—

(3012516) Albumin [Mass/volume] in Urine

468

1.79

3.83

4.7

3.5

mg/l

2622.4

192.4

0.98

334

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

170

1409

1.84

3.80

4.7

3.5

mu/l

1.8

2.0

0.97

155

1296

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

137

1068

1.72

3.79

5.6

3.8

ug/l

8.9

1.7

0.58

126

960

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

245

1.99

3.75

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

324

1.88

3.70

3.1

3.8

ng/l

1859.7

838.5

0.26

262

(3024980) IgG subclass 4 [Mass/volume] in Serum

3.80

3.68

1.1

1.3

g/l

0.6

0.9

—

(3042936) Bacteria identified in Isolate by Culture

247

1.97

3.67

1.5

2.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

529

1.73

3.54

3.5

3.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

10.23

3.51

1.0

—

(3049717) Cytology report of Urine Cyto stain

2.96

3.43

2.7

2.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3.56

3.38

1.4

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

179

2.06

3.37

3.2

2.9

ug/g

81.8

154.9

1.78

152

(40768804) Tissue Pathology biopsy report

527

1.70

3.36

2.1

2.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

200

1772

2.16

3.36

19.8

15.6

mmol/l

4.0

0.01

195

1728

(3020682) Albumin/Creatinine [Ratio] in Urine

502

1.71

3.33

5.4

4.2

mg/mmol

5.3

8.7

0.66

354

(3023368) Bacteria identified in Blood by Culture

454

1.71

3.23

3.9

4.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

290

1.83

3.20

1.4

g/l

2.6

0.13

195

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

499

1.69

3.17

4.3

2.9

u/l

57.0

56.2

0.10

473

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

364

1.76

3.16

2.4

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

440

1.71

3.14

4.9

3.6

mmol/l

2.3

0.14

396

(3013650) Neutrophils [#/volume] in Blood by Automated count

121

944

1.61

3.08

10.4

10.3

e9/l

4.0

4.1

0.33

112

829

(3003694) ABO and Rh group [Type] in Blood

444

1.69

3.03

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

211

1926

2.54

3.02

13.1

9.6

u/l

31.2

33.6

1.23

206

1877

(3045414) Leukocytes [Presence] in Urine

3.11

3.02

1.2

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

723

1.60

2.96

2.8

2.7

estimate

0.0

0.00

104

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

282

1.79

2.91

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

475

1.65

2.89

2.3

2.5

—

(3044290) Cell count panel - Cerebral spinal fluid

4.03

2.80

1.0

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

8.48

2.76

1.6

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

8.48

2.76

1.6

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

8.48

2.76

1.6

1.0

—

(4062490)

5.12

2.75

1.0

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

216

2025

2.67

2.74

25.2

18.4

e12/l

4.7

4.8

0.48

210

1964

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

330

1.71

2.67

1.9

mg/l

0.8

1.3

1.58

246

(3021601) Nitrite [Presence] in Urine by Test strip

718

1.56

2.66

3.8

estimate

0.0

—

110

(1761868) Lipid panel - Serum or Plasma

740

0.60

2.66

2.4

2.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

137

2.02

2.58

2.5

2.3

g/l

10.6

10.9

0.11

120

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

7.27

2.56

1.4

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

7.27

2.56

1.6

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

5.57

2.56

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

5.57

2.56

1.7

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.12

2.56

1.8

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.76

2.49

1.2

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.64

2.49

2.1

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

709

1.53

2.47

2.8

2.7

estimate

0.0

0.00

104

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

425

1.60

2.39

3.4

ng/l

1451.7

1246.4

0.12

358

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

567

1.54

2.37

2.1

1.8

pmol/l

94.3

89.9

0.34

336

(3002032) Base excess in Venous blood by calculation

157

1.89

2.35

3.9

3.8

mmol/l

1.3

1.5

0.13

127

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

196

1.80

2.32

1.4

1.2

u/ml

1.6

8.7

—

(3028707) Methadone [Presence] in Urine by Screen method

2.77

2.31

10.3

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

174

1.84

2.27

1.6

1.7

—

(3012544) pH of Venous blood

160

1.86

2.22

4.3

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

255

1.69

2.21

1.7

1.9

—

(40761511) CBC panel - Blood by Automated count

202

1853

1.88

2.20

17.0

11.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

138

1161

1.49

2.18

3.4

2.9

—

(3026008) Bacteria identified in Urine by Culture

232

1.71

2.17

4.2

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

162

1.83

2.14

5.1

7.2

—

(3033658) Prothrombin time (PT) actual/Normal

418

1.56

2.14

4.5

4.4

90.9

88.1

0.47

413

(3026389) Candida sp identified in Specimen by Organism specific culture

5.08

2.08

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

2.48

2.06

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

4.08

2.05

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

130

1090

1.46

2.03

3.6

2.9

pmol/l

14.9

14.8

0.24

118

995

(36660697) Celiac disease serology panel - Serum

105

1.99

2.03

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.08

1.96

7.1

2.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.62

1.95

1.4

2.2

u/ml

901.6

854.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.82

1.95

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

100

1.98

1.92

2.8

4.0

e9/l

4.2

0.00

(3011288) Drugs identified in Urine by Screen method

2.16

1.91

8.9

2.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

192

1.71

1.90

19.7

22.2

inr

1.5

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

637

1.45

1.89

4.8

3.9

u/l

30.5

38.6

1.86

601

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.23

1.83

1.2

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

3.39

1.76

1.3

1.6

e6/l

234.8

2345.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

179

1618

1.52

1.75

7.0

5.4

mmol/mol

41.2

39.9

0.95

159

1527

(3026493) Urate [Moles/volume] in Serum or Plasma

454

1.47

1.73

3.0

2.5

umol/l

335.1

8558.8

2.08

406

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.91

1.72

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.91

1.72

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

393

1.49

1.71

2.3

—

(3039000) Anion gap in Blood

2.45

1.70

9.1

17.5

mmol/l

11.9

12.8

—

(3018572) Chloride [Moles/volume] in Blood

2.45

1.70

9.1

17.5

mmol/l

104.8

105.0

—

(3000850) Epithelial cells [#/volume] in Urine

290

1.55

1.69

2.8

2.3

e6/l

2.6

3.0

0.19

253

(3004588) Protein electrophoresis panel - Serum or Plasma

2.00

1.69

2.4

3.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

159

1.72

1.68

11.4

9.2

mmol/l

9.6

10.0

0.11

151

(3025468) Yersinia sp identified in Specimen by Organism specific culture

3.21

1.67

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

3.21

1.67

1.2

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

3.21

1.67

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

3.21

1.67

1.2

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

3.21

1.67

1.3

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.91

1.67

14.7

20.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

224

1.61

1.67

1.8

1.6

nmol/l

960.6

999.1

0.11

177

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.21

1.64

2.1

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

102

841

1.39

1.64

5.0

3.4

19.3

22.5

1.34

318

(3000991) Gas panel - Venous blood

145

1.73

1.62

9.8

12.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

560

1.42

1.61

3.0

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

3.05

1.59

1.2

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

3.05

1.59

1.2

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

181

1651

1.49

1.58

13.1

11.9

ml/min/173m2

86.1

85.7

0.08

152

1369

(3001122) Ferritin [Mass/volume] in Serum or Plasma

554

1.41

1.56

3.0

2.4

ug/l

214.5

220.8

0.04

516

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.64

1.52

1.6

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

213

1.59

1.51

1.4

1.2

iu/ml

9.9

41.0

—

(3018095) Leukocytes [#/volume] in Urine

495

1.41

1.47

4.1

3.3

e6/l

16.2

123.9

0.98

354

(3002582) Erythrocytes [#/volume] in Urine

441

1.42

1.46

3.4

2.9

e6/l

17.8

208.2

0.69

332

(4035726)

126

1.74

1.46

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

309

1.48

1.45

1.3

1.2

u/ml

0.9

1.2

0.52

(3045788) Cell count panel - Pleural fluid

3.17

1.44

1.2

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.17

1.44

2.0

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.95

1.42

7.4

11.8

1.8

0.05

(3003396) Base excess in Arterial blood by calculation

192

1.59

1.41

10.2

13.4

mmol/l

1.9

0.9

1.44

147

(4306422)

2.46

1.40

1.0

1.4

—

(3037756) Immunofixation for Serum or Plasma

2.46

1.40

2.0

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.24

1.38

3.0

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

151

1349

1.36

1.37

4.6

3.1

u/l

43.1

54.9

2.67

144

1293

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

194

1.57

1.35

1.2

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.19

1.35

1.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2.19

1.35

1.4

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.84

1.30

1.8

2.2

u/l

39.9

39.6

0.01

(3045424) Erythrocytes [Presence] in Urine

2.82

1.29

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

180

1.57

1.28

1.7

2.1

1.6

1.8

0.28

165

(3026782) Osmolality of Urine

291

1.46

1.27

2.7

2.5

mosm/kgh2o

626.7

603.9

0.24

238

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.91

1.27

7.8

12.5

1.1

0.9

1.22

(3000764) Benzodiazepines [Presence] in Urine

116

1.70

1.26

6.5

2.0

—

(3027944) Amphetamines [Presence] in Urine

116

1.70

1.26

4.9

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.67

1.22

1.2

1.8

—

(3027008) Opiates [Presence] in Urine

118

1.67

1.19

6.4

2.0

—

(3028300) Cannabinoids [Presence] in Urine

118

1.67

1.19

6.6

2.0

—

(4010399)

118

1.67

1.19

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.85

1.17

1.3

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

119

1.65

1.16

1.8

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.89

1.16

2.2

1.5

iu/ml

0.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

2.53

1.15

1.6

1.9

g/l

23.0

31.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.53

1.15

1.2

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.53

1.15

1.2

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

359

1.39

1.15

3.1

4.5

—

(36304419) Bacteria [Presence] in Urine

396

1.37

1.14

3.1

2.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

246

1.45

1.12

2.7

e6/l

0.3

0.4

0.22

130

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.30

1.11

1.1

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

194

1827

1.45

1.11

5.3

4.5

mmol/l

2.8

0.10

176

1711

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.86

1.11

2.6

2.1

ug/l

0.5

1.3

0.47

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.41

1.09

1.2

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

213

1.47

1.09

1.5

1.8

—

(3008898) HLA-B27 [Presence]

1.97

1.08

1.3

1.1

—

(3019060) Gas panel - Arterial blood

114

1.63

1.06

5.7

8.8

—

(3016879) Cocaine [Presence] in Urine

106

1.65

1.06

7.2

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

191

1798

1.41

1.05

4.8

4.1

mmol/l

4.7

4.6

0.41

176

1694

(3019150) Specific gravity of Urine by Refractometry

329

1.38

1.05

4.0

2.9

kg/l

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2.00

1.05

1.1

1.0

—

7.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.09

1.04

1.0

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

156

1.53

1.03

9.9

10.3

mmol/l

1.3

1.4

0.15

148

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

277

1.40

1.02

1.7

pmol/l

267742307.7

392.5

0.49

242

(3029937) Albumin [Presence] in Urine by Test strip

349

1.36

1.01

3.5

2.8

estimate

0.0

0.50

(3021901) Oxygen saturation in Capillary blood

2.20

0.98

1.8

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

190

1793

1.38

0.97

4.8

4.1

mmol/l

1.3

0.25

171

1675

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

101

1.63

0.96

1.4

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2.25

0.94

1.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

418

1.32

0.93

1.7

1.6

mmol/l

1.6

1.5

0.21

354

(40760888) Immunoglobulin light chains.free panel - Serum

2.17

0.92

4.2

5.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

256

1.39

0.92

2.6

2.5

e6/l

0.6

0.7

0.13

139

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

328

1.34

0.91

2.2

2.0

mg/l

2.8

3.1

0.34

286

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1.70

0.87

1.3

1.5

g/l

1.4

1.6

0.47

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

147

1.47

0.84

2.1

2.4

ug/l

10.7

11.2

0.03

136

(40761535) Cells panel - Urine sediment

114

1.53

0.82

3.7

3.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.73

0.81

1.4

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

182

1721

1.30

0.80

17.7

14.0

41.5

42.1

0.32

129

1350

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.62

0.80

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

186

1.39

0.74

1.6

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

404

1.27

0.73

3.0

2.8

e6/l

0.1

0.4

2.34

293

(3024928) Oxygen saturation in Venous blood

1.82

0.73

4.0

2.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.94

0.71

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.73

0.70

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.62

0.69

1.1

1.3

iu/ml

365.6

88.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

183

1741

1.27

0.69

4.3

3.8

mmol/l

1.5

1.4

1.13

167

1632

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.69

0.69

1.9

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.69

0.69

1.6

1.7

—

(3045142) Bone marrow Pathology biopsy report

1.87

0.69

1.0

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1.64

0.66

1.1

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

121

1.44

0.64

4.3

2.5

ml/min/173m2

77.3

69.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

177

1683

1.24

0.64

5.2

4.1

mmol/l

6.2

6.1

0.52

156

1553

(3017181) Myelocytes/100 leukocytes in Blood

131

1.41

0.61

1.8

4.3

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.47

0.60

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

185

1.33

0.59

1.6

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

331

1.25

0.59

3.2

2.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.53

0.57

1.7

1.5

—

(3003338) MCHC [Mass/volume]

154

1623

0.84

0.56

22.0

16.2

g/l

335.8

336.3

0.29

154

1616

(4034850)

1.56

0.56

8.5

7.9

—

(3018418) pH of Serum or Plasma

418

1.22

0.55

7.4

4.6

7.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.51

0.52

4.2

5.0

mg/l

23.7

40.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

613

1.18

0.51

3.1

2.4

ug/l

0.6

0.7

1.25

342

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

237

1.26

0.48

3.9

3.2

mmol/l

2.4

0.04

209

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.45

4.0

3.6

—

(40761536) Microorganisms panel - Urine sediment

1.39

0.45

2.2

2.5

—

(4094501)

1.38

0.44

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.63

0.43

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.63

0.43

1.0

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.63

0.43

1.4

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.53

0.41

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.41

0.41

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.41

0.0

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.41

0.0

6.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

2.5

—

(3000330) Specific gravity of Urine by Test strip

1.35

0.40

1.5

3.2

—

(3025941) Bacteria identified in Stool by Culture

1.39

0.39

2.1

1.2

—

(3021589) Normoblasts [#/volume] in Blood

723

0.88

0.36

9.1

e9/l

0.0

0.46

585

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.36

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.48

0.36

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.44

0.36

1.3

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

322

1.18

0.35

1.6

1.5

nmol/l

18.2

18.5

0.04

283

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.37

0.34

1.2

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.31

0.33

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.34

0.32

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

165

1.23

0.32

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.32

0.32

15.8

16.1

mmol/l

25.6

24.4

0.91

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.31

0.30

15.1

12.0

mmol/l

26.5

24.6

1.10

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

205

0.82

0.29

1.8

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1.18

0.24

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(4027681)

0.00

0.21

0.0

1.2

—

(3017569) Oxygen content in Arterial blood

0.00

0.21

0.0

7.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.3

—

8.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.21

0.0

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

6.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.21

0.0

2.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.20

0.0

7.3

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.20

0.0

2.1

—

481.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.20

0.0

1.1

—

(3020891) Body temperature

1.17

0.16

3.3

4.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.17

0.16

1.9

1.2

—

(40758558) Short blood count panel - Blood

391

1.09

0.16

10.0

6.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

140

0.85

0.15

1.4

1.3

—

(1002224) Polysomnography panel

100

0.79

0.14

1.0

—

(3000492) Spirometry study

221

0.90

0.13

1.2

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

280

1.08

0.11

2.4

2.5

30.2

30.3

0.04

272

(21494755) Public health laboratory ask at order entry panel

279

0.92

0.10

1.2

1.4

—

(3002256) Pathology report gross observation

164

1.11

0.10

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

1.2

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.09

0.09

2.6

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

215

1.08

0.08

3.5

2.4

28.3

24.2

0.38

196

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

160

0.93

0.04

3.3

2.8

—

(3044889) 12 lead EKG panel

120

1211

0.98

0.02

3.8

3.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.04

0.00

1.2

1.5

—

(3004451) EKG impression Narrative

0.00

0.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.2

—

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

6.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

2.0

—

58.8

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

110.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.94

0.00

1.6

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.0

1.8

—

49.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

245.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.5

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.0

1.4

—

(3013762) Body weight Measured

0.00

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.98

0.00

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.0

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(4024509)

0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

2.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_MALEGENINOTH and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
N14_MALEGENINOTH	1.305 [1.07, 1.59]	0.008
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 156 out of 1765 males with N14_MALEGENINOTH died.

Mortality risk

Mortality risk for people of age

years, who have N14_MALEGENINOTH.

N-year risk	Females	Males
1	No data	0.236%
5	No data	1.558%
10	No data	3.758%
15	No data	7.027%
20	No data	11.796%

Relationships between endpoints

↥

Index endpoint: N14_MALEGENINOTH – Disorders of male genital organs in diseases classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of male genital organs in diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints